Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3287157
Max Phase: Preclinical
Molecular Formula: C18H23ClN4O2S
Molecular Weight: 358.47
Molecule Type: Small molecule
Associated Items:
ID: ALA3287157
Max Phase: Preclinical
Molecular Formula: C18H23ClN4O2S
Molecular Weight: 358.47
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.N=C(N)c1ccc(OCCSCCOc2ccc(C(=N)N)cc2)cc1
Standard InChI: InChI=1S/C18H22N4O2S.ClH/c19-17(20)13-1-5-15(6-2-13)23-9-11-25-12-10-24-16-7-3-14(4-8-16)18(21)22;/h1-8H,9-12H2,(H3,19,20)(H3,21,22);1H
Standard InChI Key: GDJCYTLIWVKCPB-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 358.47 | Molecular Weight (Monoisotopic): 358.1463 | AlogP: 2.45 | #Rotatable Bonds: 10 |
Polar Surface Area: 118.20 | Molecular Species: BASE | HBA: 5 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 12.13 | CX LogP: 1.83 | CX LogD: -2.99 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.30 | Np Likeness Score: -0.51 |
1. Maciejewska D, Żabiński J, Kaźmierczak P, Wójciuk K, Kruszewski M, Kruszewska H.. (2014) In vitro screening of pentamidine analogs against bacterial and fungal strains., 24 (13): [PMID:24830598] [10.1016/j.bmcl.2014.04.075] |
Source(1):